The benefits of experimental cancer drugs could be inflated when clinical trials are halted early, a study in the latest issue of the Annals of Oncology suggests.
Monitoring boards can halt clinical trials if a medicine appears to have a serious safety baggage, if it shows no benefit or if it appears to show so much [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment